These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33898768)

  • 1. miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.
    Tanaka S; Hosokawa M; Miyamoto T; Nakagawa A; Haruna M; Ueda K; Iwakawa S; Ogawara KI
    Biochem Biophys Rep; 2021 Jul; 26():100996. PubMed ID: 33898768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA-20b-3p/DEPDC1 axis.
    Zhao B; Wang Y; Zhao X; Ni J; Zhu X; Fu Y; Yang F
    Cell Biol Int; 2022 Dec; 46(12):2107-2117. PubMed ID: 36200529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy.
    Sasaki M; Ishikawa T; Ishiguro M; Okazaki S; Yamauchi S; Kikuchi A; Matsuyama T; Kawada K; Tokunaga M; Uetake H; Kinugasa Y
    Oncol Lett; 2021 Jun; 21(6):489. PubMed ID: 33968205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway.
    He Y; Zhang L; Tan F; Wang LF; Liu DH; Wang RJ; Yin XZ
    Biosci Biotechnol Biochem; 2020 Aug; 84(8):1645-1651. PubMed ID: 32380907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
    Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.
    Pan J; Zhou C; Zhao X; He J; Tian H; Shen W; Han Y; Chen J; Fang S; Meng X; Jin X; Gong Z
    Sci Rep; 2018 Nov; 8(1):16699. PubMed ID: 30420640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer.
    Li M; Liu T; Cheng W; Jin H; Wang X
    J Thorac Dis; 2023 May; 15(5):2616-2626. PubMed ID: 37324093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
    Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
    Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
    Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.
    Ostenfeld MS; Jensen SG; Jeppesen DK; Christensen LL; Thorsen SB; Stenvang J; Hvam ML; Thomsen A; Mouritzen P; Rasmussen MH; Nielsen HJ; Ørntoft TF; Andersen CL
    J Extracell Vesicles; 2016; 5():31488. PubMed ID: 27576678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
    Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
    Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer.
    Fu F; Jiang W; Zhou L; Chen Z
    Transl Oncol; 2018 Apr; 11(2):221-232. PubMed ID: 29367070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of purposeful soccer heading on circulating small extracellular vesicle concentration and cargo.
    Muñoz ER; Caccese JB; Wilson BE; Shuler KT; Santos FV; Cabán CT; Jeka JJ; Langford D; Hudson MB
    J Sport Health Sci; 2021 Mar; 10(2):122-130. PubMed ID: 33189894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p.
    Han W; Yin H; Ma H; Wang Y; Kong D; Fan Z
    Evid Based Complement Alternat Med; 2020; 2020():8394574. PubMed ID: 33014113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
    Guan X; Gu S; Yuan M; Zheng X; Wu J
    Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.